trastuzumab resistance

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Care Career buys MAS Medical Staffing to expand healthcare workforce platform

China uses water cannon against Philippine vessels for second day near Scarborough Shoal

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

IBM’s planned acquisition of HRL Laboratories could strengthen its quantum computing roadmap by adding silicon-spin qubit technology and expanding its advanced semiconductor research capabilities. Representative image.

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

ATNM-400 from Actinium Pharmaceuticals (ATNM) shows breakthrough promise in resistant breast cancer

Actinium’s ATNM-400 shows potent activity in resistant breast cancer and TNBC. Find out what the new SABCS 2025 data reveal about this radiopharma candidate.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

December 1, 2025